CA-125 serum level in the diagnosis of pelvic masses: comparison with other methods.
The Authors have evaluated the diagnostic contribution offered by the serum dosage of the antigen CA-125 in the diagnostics of pelvic masses. This method has been compared with the objective and echographic evaluation, as a noninvasive method of enquiry in the diagnosis of malignant neoplasias of the ovary. The Authors endorse the increase in diagnostic sensitivity brought about by the evaluation of this marker, above all if it is inserted into an integrated diagnosis.
Maggino
T
T
Institute of the Obstetric and Gynecological Clinic, University of Padua, Italy.
Sopracordevole
F
F
Matarese
M
M
Di Pasquale
C
C
Tambuscio
G
G
D000328:Adult; D000951:Antigens, Neoplasm / Q000032:analysis*; D000954:Antigens, Surface / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D003536:Cystadenocarcinoma / Q000175:diagnosis*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis*; D010386:Pelvic Neoplasms / Q000175:diagnosis*; D014463:Ultrasonography
D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D015295:Antigens, Tumor-Associated, Carbohydrate